DE69630630D1 - Staphylococcus aureus V8 Protease Mutanten - Google Patents

Staphylococcus aureus V8 Protease Mutanten

Info

Publication number
DE69630630D1
DE69630630D1 DE69630630T DE69630630T DE69630630D1 DE 69630630 D1 DE69630630 D1 DE 69630630D1 DE 69630630 T DE69630630 T DE 69630630T DE 69630630 T DE69630630 T DE 69630630T DE 69630630 D1 DE69630630 D1 DE 69630630D1
Authority
DE
Germany
Prior art keywords
urea
concentrations
enzyme
staphylococcus aureus
protease mutants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69630630T
Other languages
English (en)
Other versions
DE69630630T2 (de
Inventor
Masayuki Yabuta
Kazuhiro Ohsuye
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of DE69630630D1 publication Critical patent/DE69630630D1/de
Publication of DE69630630T2 publication Critical patent/DE69630630T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Detergent Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69630630T 1995-06-02 1996-05-31 Staphylococcus aureus V8 Protease Mutanten Expired - Lifetime DE69630630T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP17008695 1995-06-02
JP17008695 1995-06-02

Publications (2)

Publication Number Publication Date
DE69630630D1 true DE69630630D1 (de) 2003-12-18
DE69630630T2 DE69630630T2 (de) 2004-09-23

Family

ID=15898392

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69630630T Expired - Lifetime DE69630630T2 (de) 1995-06-02 1996-05-31 Staphylococcus aureus V8 Protease Mutanten

Country Status (9)

Country Link
US (1) US5747321A (de)
EP (1) EP0745669B1 (de)
JP (1) JP3852982B2 (de)
KR (1) KR100650960B1 (de)
AT (1) ATE254177T1 (de)
DE (1) DE69630630T2 (de)
ES (1) ES2206546T3 (de)
HU (1) HUP9601487A3 (de)
IL (2) IL118473A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1090132A1 (de) * 1998-06-26 2001-04-11 PPL Therapeutics (Scotland) Limited Verfahren zur herstellung von rekombinanten polypetide
US7385026B1 (en) 1999-07-23 2008-06-10 Kenji Kangawa Modified ghrelin polypeptides
EP1214426A2 (de) * 1999-08-31 2002-06-19 Novozymes A/S Neue proteasen und deren varianten
US7217554B2 (en) * 1999-08-31 2007-05-15 Novozymes A/S Proteases and variants thereof
US6558939B1 (en) * 1999-08-31 2003-05-06 Novozymes, A/S Proteases and variants thereof
CN1267551C (zh) * 1999-10-19 2006-08-02 印度生物技术国际有限公司 重组成熟溶葡萄球菌素的表达
BRPI0306644B8 (pt) 2002-04-11 2021-05-25 Asubio Pharma Co Ltd método para produzir um peptídeo modificado

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0399816B1 (de) * 1989-05-24 1995-12-20 Merck & Co. Inc. Reinigung und Charakterisierung eines von einem Glioma abstammenden Wachstumsfaktors
US5536655A (en) * 1989-09-26 1996-07-16 Midwest Research Institute Gene coding for the E1 endoglucanase
ATE253639T1 (de) * 1991-08-19 2003-11-15 Daiichi Suntory Pharma Co Ltd Verfahren zur herstellung von peptiden

Also Published As

Publication number Publication date
JP3852982B2 (ja) 2006-12-06
DE69630630T2 (de) 2004-09-23
ATE254177T1 (de) 2003-11-15
HUP9601487A2 (en) 1997-05-28
HU9601487D0 (en) 1996-08-28
JPH0947291A (ja) 1997-02-18
KR970001536A (ko) 1997-01-24
KR100650960B1 (ko) 2007-03-02
EP0745669B1 (de) 2003-11-12
US5747321A (en) 1998-05-05
IL118473A0 (en) 1996-09-12
IL118473A (en) 2005-03-20
HUP9601487A3 (en) 2001-08-28
EP0745669A3 (de) 1999-05-26
EP0745669A2 (de) 1996-12-04
ES2206546T3 (es) 2004-05-16

Similar Documents

Publication Publication Date Title
Tokunaga et al. The factor V-activating enzyme (RVV-V) from Russell's viper venom. Identification of isoproteins RVV-V alpha,-V beta, and-V gamma and their complete amino acid sequences.
DE69628656D1 (de) Mannase von bacillus amyloliquefaciens und methode zu ihrer preparation
DE69613856D1 (de) Thermostabile dna polymerase aus thermoanaerobacter thermohydrosulfuricus und davon abgeleitete mutierte enzyme mit entfernter exonukleaseaktivität
SE8800238D0 (sv) Flytande enzymkompositioner
DE60133802D1 (de) Verwendung von säurestabilen proteasen in tierfutter
ATE103632T1 (de) Enzymatische waschmittelzusammensetzung und verfahren zum stabilisieren der enzyme.
BR9407834A (pt) Composições de limpeza contendo protease
ATE184289T1 (de) Ribosomen-inaktivierende proteine, inaktive vorläuferformen derselben, verfahren zur herstellung und eine methode zur nutzung
DK0506791T3 (da) Enzymholdigt præparat og detergent indeholdende et sådant præparat
MA23330A1 (fr) Serine protease a absorption diminuee et hydrolyse accrue .
DE69534467D1 (de) Modifikation des starke-gehalts in pflanzen
SE8801701D0 (sv) Production technology based on enzymic method
DE69630630D1 (de) Staphylococcus aureus V8 Protease Mutanten
Welgus et al. The gelatinolytic activity of rat uterus collagenase.
DE59009945D1 (de) Mittel zur hemmung von hiv-proteasen.
Kaneda et al. Purification and some properties of a protease from the sarcocarp of musk melon fruit
DE69736076D1 (de) Enzyme mit s-adenosyl-l-homocystein-hydrolase-ähnlicher aktivität.
ES2171136A1 (es) Enzima con actividad proteolitica construccion de adn que comprende una secuencia de adn que codifica dicha enzima y sus aplicaciones.
NO933503D0 (no) Dicytostelium dipeptidylaminopeptidase
Arima et al. Cleavage specificity of cucumisin, a serine protease, with synthetic substrates
DK0667872T3 (da) Mutantinterleukin 6 med forbedret biologisk aktivitet i forhold til vildtype-interleukin 6
DK0512087T3 (da) Fremgangsmåde til reaktivering af denaturerede proteiner
Torres et al. Bmoo FIBMP-I: a new fibrinogenolytic metalloproteinase from Bothrops moojeni snake venom
Han et al. Stability of protease Q against autolysis and in sodium dodecyl sulfate and urea solutions
GUdzeNkO et al. IsolatIon and characterIzatIon of Bacillus sp. IMV B-7883 proteases

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SANKYO COMPANY, LIMITED, TOKIO, JP